Reactive_JJ Nitrogen_NP Intermediates_NP Have_VBP a_DT Bacteriostatic_JJ Effect_NN on_IN Mycobacterium_NN tuberculosis_NN In_IN Vitro_NP Susceptibility_NP of_IN six_CD isolates_NNS of_IN Mycobacterium_NN tuberculosis_NN (_( CB3.3_NP ,_, CDC1551_NP ,_, RJ2E_NP ,_, C.C.13_NP ,_, H37Rv_NP ,_, and_CC H37Ra_NP )_) and_CC two_CD isolates_NNS of_IN Mycobacterium_NP bovis_NP (_( Ravenel_NP and_CC BCG_NP )_) to_TO reactive_JJ oxygen_NN intermediates_NNS (_( ROI_NP )_) and_CC reactive_JJ nitrogen_NN intermediates_NNS (_( RNI_NP )_) was_VBD determined_VBN by_IN standard_NN in_IN vitro_NN survival_NN assays_NNS ._SENT After_IN 21_CD days_NNS of_IN incubation_NN ,_, the_DT survival_NN of_IN most_JJS strains_NNS exposed_VBN to_TO either_DT acidified_VBN sodium_NN nitrite_NN (_( ASN_NP )_) or_CC hydrogen_NN peroxide_NN (_( H2O2_NP )_) was_VBD significantly_RB lower_JJR than_IN the_DT same_JJ strains_NNS unexposed_JJ to_TO these_DT RNI_NP or_CC ROI_NP products_NNS ._SENT However_RB ,_, after_IN 50_CD days_NNS of_IN incubation_NN ,_, these_DT differences_NNS in_IN susceptibility_NN became_VBD less_RBR apparent_JJ for_IN strains_NNS exposed_VBN to_TO ASN_NP but_CC not_RB for_IN strains_NNS exposed_VBN to_TO H2O2_NP ._SENT The_DT recovery_NN of_IN these_DT strains_NNS after_IN exposure_NN to_TO RNI_NP suggests_VBZ that_IN the_DT effect_NN of_IN RNI_NP on_IN M._NP tuberculosis_NN is_VBZ bacteriostatic_JJ ._SENT The_DT in_IN vitro_NN concentrations_NNS of_IN ROI_NP and_CC RNI_NP used_VBD in_IN these_DT assays_NNS were_VBD higher_JJR than_IN those_DT expected_VBN in_IN vivo_RB ._SENT These_DT observations_NNS suggest_VBP that_IN ,_, in_IN vivo_RB ,_, RNI_NP expression_NN at_IN physiologically_RB achievable_JJ concentrations_NNS may_MD keep_VB M._NP tuberculosis_NN from_IN proliferating_VBG but_CC that_DT removal_NN of_IN RNI_NP may_MD allow_VB the_DT organisms_NNS to_TO proliferate_VB ._SENT Furthermore_RB ,_, the_DT ability_NN of_IN some_DT M._NP tuberculosis_NN strains_NNS to_TO cause_VB rapidly_RB progressive_JJ disease_NN may_MD relate_VB to_TO their_PP$ intrinsic_JJ levels_NNS of_IN RNI_NP and_CC ROI_NP resistance_NN ._SENT Although_IN current_JJ estimates_NNS suggest_VBP that_IN one_CD third_NN of_IN the_DT world_NN 's_POS population_NN is_VBZ infected_VBN with_IN Mycobacterium_NN tuberculosis_NN ,_, the_DT majority_NN of_IN such_JJ infections_NNS remain_VBP clinically_RB latent_JJ ._SENT Factors_NNS that_WDT contribute_VBP to_TO the_DT success_NN of_IN M._NP tuberculosis_NN as_IN a_DT pathogen_NN include_VBP its_PP$ ability_NN to_TO resist_VB the_DT harsh_JJ environment_NN of_IN the_DT host_NN macrophage_NN and_CC to_TO persist_VB within_IN immunocompetent_JJ hosts_NNS even_RB after_IN a_DT clinical_JJ cure_NN of_IN the_DT disease_NN is_VBZ achieved_VBN ._SENT The_DT ability_NN of_IN M._NP tuberculosis_NN to_TO cause_VB disease_NN in_IN the_DT human_JJ or_CC animal_JJ host_NN may_MD vary_VB according_VBG to_TO host_VB susceptibility_NN and_CC to_TO intrinsic_JJ biologic_JJ differences_NNS among_IN clinical_JJ strains_NNS ._SENT The_DT latter_NN may_MD reflect_VB a_DT particular_JJ strain_NN 's_POS specific_JJ adaptation_NN to_TO the_DT antimicrobial_JJ defenses_NNS of_IN the_DT host_NN macrophage_NN ._SENT For_IN example_NN ,_, numerous_JJ studies_NNS have_VBP demonstrated_VBN that_IN strains_NNS of_IN Mycobacterium_NP differ_VBP in_IN susceptibility_NN to_TO reactive_JJ oxygen_NN intermediates_NNS (_( ROI_NP )_) and_CC reactive_JJ nitrogen_NN intermediates_NNS (_( RNI_NP )_) ._SENT The_DT role_NN of_IN ROI_NP and_CC RNI_NP in_IN controlling_VBG acute_JJ infections_NNS with_IN M._NP tuberculosis_NN has_VBZ been_VBN fairly_RB well_RB studied_VBN in_IN the_DT murine_JJ system_NN ._SENT However_RB ,_, little_RB is_VBZ known_VBN about_IN the_DT role_NN of_IN these_DT intermediates_NNS during_IN latent_JJ infections_NNS ._SENT Studies_NNS have_VBP demonstrated_VBN that_IN the_DT inducible_JJ form_NN of_IN nitric_JJ oxide_NN synthase_NN (_( iNOS_NNS )_) expression_NN is_VBZ required_VBN to_TO control_VB mycobacterial_JJ infection_NN in_IN mice_NNS ._SENT However_RB ,_, the_DT induction_NN of_IN iNOS_NNS does_VBZ not_RB lead_VB to_TO complete_VB elimination_NN of_IN M._NP tuberculosis_NN in_IN vivo_RB ._SENT In_IN addition_NN ,_, Flynn_NP et_FW al._FW demonstrated_VBD that_IN M._NP tuberculosis_NN reactivation_NN occurs_VBZ if_IN the_DT production_NN of_IN RNI_NP is_VBZ inhibited_VBN in_IN a_DT murine_JJ model_NN of_IN latency_NN ._SENT This_DT suggests_VBZ that_IN reactivation_NN tuberculosis_NN may_MD result_VB from_IN the_DT removal_NN of_IN host_NN defense_NN mechanisms_NNS ,_, such_JJ as_IN RNI_NP ,_, that_WDT keep_VBP M._NP tuberculosis_NN from_IN replicating_VBG in_IN vivo_RB ._SENT Consequently_RB ,_, it_PP is_VBZ possible_JJ that_IN ROI_NP and_CC RNI_NP may_MD inhibit_VB replication_NN (_( bacteriostatic_JJ )_) but_CC do_VBP not_RB eradicate_VB the_DT bacteria_NNS (_( bactericidal_JJ )_) ._SENT We_PP decided_VBD to_TO test_VB this_DT concept_NN in_IN vitro_NN by_IN using_VBG RNI_NP and_CC ROI_NP susceptibility_NN assays_NNS applied_VBN to_TO both_DT clinical_JJ and_CC laboratory_NN strains_NNS of_IN mycobacteria_NNS ._SENT The_DT mycobacterial_JJ strains_NNS used_VBN in_IN the_DT present_JJ study_NN are_VBP listed_VBN in_IN Table_NP ._SENT All_DT strains_NNS of_IN Mycobacterium_NP were_VBD grown_VBN in_IN Middlebrook_NP 7H9_JJ broth_NN with_IN 0.5_CD %_NN glycerol_NN ,_, 0.02_CD %_NN Tween_NP 80_CD ,_, and_CC 10_CD %_NN ADC_NP enrichment_NN to_TO mid-log_NN phase_NN ._SENT Single-cell_NN suspensions_NNS of_IN each_DT isolate_NN were_VBD prepared_VBN according_VBG to_TO a_DT previously_RB published_VBN method_NN and_CC quantified_VBN by_IN enumeration_NN of_IN their_PP$ CFU_NP on_IN Middlebrook_NP 7H11_JJ agar_NN plates_NNS ._SENT A_DT 0.1-ml_NN aliquot_NN of_IN this_DT suspension_NN was_VBD added_VBN to_TO 0.9_CD ml_NN of_IN 7H9_JJ broth_NN (_( pH_NN 5.3_CD for_IN ASN_NP assays_NNS or_CC pH_NN 7.0_CD for_IN H2O2_NP assays_NNS )_) containing_VBG various_JJ concentrations_NNS of_IN either_DT sodium_NN nitrite_NN (_( NaNO2_NP )_) or_CC hydrogen_NN peroxide_NN (_( H2O2_NP )_) ._SENT As_IN a_DT control_NN ,_, the_DT culture_NN was_VBD added_VBN to_TO 7H9_JJ broth_NN at_IN the_DT appropriate_JJ pH_NN without_IN NaNO2_NP or_CC H2O2_NP (_( unexposed_JJ )_) ._SENT Each_DT suspension_NN was_VBD incubated_VBN at_IN 37C_JJ for_IN 24_CD h_NN ,_, plated_VBN onto_IN 7H11_JJ agar_NN ,_, and_CC incubated_VBN at_IN 37C_JJ for_IN 3_CD weeks_NNS ._SENT At_IN day_NN 21_CD (_( or_CC day_NN 26_CD for_IN H37Ra_NP )_) ,_, the_DT CFU_NP recovered_VBD from_IN isolates_NNS exposed_VBN to_TO either_DT ASN_NP or_CC H2O2_NP were_VBD marked_VBN ,_, quantified_VBN ,_, and_CC compared_VBN to_TO the_DT CFU_NP for_IN recovered_VBN isolates_NNS not_RB exposed_VBN to_TO ASN_NP or_CC H2O2_NP ;_: the_DT data_NNS were_VBD then_RB calculated_VBN as_IN the_DT percent_NN survival_NN (_( [_SYM number_NN of_IN CFU_NP exposed_VBN at_IN day_NN 21/number_JJ of_IN CFU_NP unexposed_JJ at_IN day_NN 21_CD ]_SYM x_SYM 100_CD )_) ._SENT Incubation_NN at_IN 37C_NP was_VBD allowed_VBN to_TO continue_VB to_TO day_NN 50_CD ,_, at_IN which_WDT time_NN each_DT plate_NN was_VBD reexamined_VBN to_TO enumerate_VB additional_JJ CFU_NP recovered_VBD during_IN the_DT interval_NN ._SENT The_DT total_JJ number_NN of_IN CFU_NP was_VBD again_RB compared_VBN to_TO the_DT total_JJ number_NN of_IN CFU_NP from_IN recovered_VBN isolates_NNS not_RB exposed_VBN to_TO ASN_NP or_CC H2O2_NP at_IN 50_CD days_NNS of_IN incubation_NN ,_, and_CC the_DT data_NNS were_VBD converted_VBN to_TO percent_NN survival_NN (_( [_SYM number_NN of_IN CFU_NP exposed_VBN at_IN day_NN 50/number_NN of_IN CFU_NP unexposed_JJ at_IN day_NN 50_CD ]_SYM x_SYM 100_CD )_) ._SENT Each_DT strain_NN was_VBD tested_VBN similarly_RB in_IN triplicate_NN ,_, and_CC each_DT assay_NN was_VBD repeated_VBN at_IN least_JJS twice_RB ._SENT Comparison_NN of_IN the_DT mean_JJ CFU_NP recovery_NN of_IN each_DT strain_NN was_VBD made_VBN by_IN Student_NP t_NN test_NN ,_, and_CC a_DT P_NN value_NN of_IN <0.05_NN was_VBD considered_VBN to_TO show_VB a_DT significant_JJ difference_NN ._SENT TABLE_NN 1_CD |_SYM Mycobacterial_JJ strains_NNS used_VBN in_IN this_DT study_NN Each_DT strain_NN of_IN mycobacteria_NNS demonstrated_VBN similar_JJ levels_NNS of_IN growth_NN between_IN days_NNS 21_CD and_CC 50_CD when_WRB not_RB exposed_VBN to_TO ASN_NP or_CC H2O2_NP (_( Fig._NN and_CC )_) ._SENT At_IN day_NN 21_CD ,_, at_IN a_DT lower_JJR concentration_NN of_IN ASN_NP (_( 3_CD mM_NNS )_) ,_, the_DT percent_NN survival_NN of_IN all_DT strains_NNS of_IN mycobacteria_NNS was_VBD <=80_JJ %_NN compared_VBN to_TO the_DT same_JJ strains_NNS not_RB exposed_VBN to_TO ASN_NP ._SENT At_IN day_NN 50_CD ,_, however_RB ,_, the_DT percent_NN survival_NN of_IN all_DT of_IN the_DT clinical_JJ strains_NNS exceeded_VBD 80_CD %_NN ._SENT Compared_VBN to_TO the_DT laboratory_NN strain_NN H37Ra_NP ,_, at_IN 3_CD mM_NP ASN_NP all_RB of_IN the_DT clinical_JJ strains_NNS of_IN M._NP tuberculosis_NN and_CC M._NP bovis_NP (_( Ravenel_NP and_CC BCG_NP )_) were_VBD significantly_RB more_RBR resistant_JJ at_IN day_NN 21_CD or_CC 50_CD of_IN incubation_NN (_( P_NN <_SYM 0.05_CD ,_, Student_NP t_NN test_NN )_) (_( Fig._NN and_CC Table_NN )_) ._SENT In_IN addition_NN ,_, at_IN 3_CD mM_NP ASN_NP the_DT percent_NN survival_NN at_IN day_NN 21_CD versus_CC that_IN at_IN day_NN 50_CD was_VBD significantly_RB different_JJ for_IN each_DT strain_NN ._SENT On_IN the_DT other_JJ hand_NN ,_, at_IN a_DT higher_JJR concentration_NN of_IN ASN_NP (_( 6_CD mM_NNS )_) ,_, the_DT percent_NN survival_NN of_IN the_DT strains_NNS at_IN days_NNS 21_CD and_CC 50_CD showed_VBD no_DT significant_JJ difference_NN ,_, except_IN for_IN H37Ra_NP and_CC M._NP bovis_NP Ravenel_NP ._SENT At_IN 6_CD mM_NP ASN_NP all_RB of_IN the_DT strains_NNS ,_, except_IN M._NP bovis_NP BCG_NP ,_, remained_VBD relatively_RB resistant_NN compared_VBN to_TO H37Ra_NP ._SENT At_IN 2_CD mM_NP H2O2_NP ,_, H37Ra_NP and_CC one_CD clinical_JJ isolate_NN (_( C.C.13_NP )_) were_VBD most_RBS susceptible_JJ compared_VBN to_TO the_DT other_JJ strains_NNS tested_VBN ,_, but_CC no_DT significant_JJ difference_NN was_VBD detected_VBN between_IN the_DT two_CD time_NN points_NNS of_IN incubation_NN for_IN each_DT strain_NN ,_, except_IN with_IN H37Ra_NP ._SENT At_IN 5_CD mM_NP H2O2_NP all_RB of_IN the_DT strains_NNS except_IN H37Rv_NP and_CC a_DT clinical_JJ strain_NN (_( C.C.13_NP )_) remained_VBD relatively_RB resistant_NN compared_VBN to_TO the_DT laboratory_NN strain_NN H37Ra_NP ._SENT At_IN 5_CD mM_NP H2O2_NP ,_, no_DT significant_JJ differences_NNS in_IN the_DT percent_NN survival_NN were_VBD observed_VBN for_IN each_DT individual_JJ strain_NN at_IN day_NN 21_CD versus_IN day_NN 50_CD except_IN with_IN H37Ra_NP ._SENT Two_CD of_IN the_DT clinical_JJ isolates_NNS (_( CB3.3_NP and_CC CDC1551_NP )_) consistently_RB exhibited_VBD the_DT highest_JJS resistance_NN to_TO killing_VBG by_IN 5_CD mM_NP H2O2_NP or_CC 6_CD mM_NP ASN_NP compared_VBD to_TO all_DT of_IN the_DT other_JJ strains_NNS tested_VBN in_IN the_DT present_JJ study_NN (_( Fig._NN and_CC )_) ._SENT FIG._NN 1_CD ._SENT |_SYM Mycobacterial_NP ASN_NP susceptibility_NN assays_NNS ._SENT Mycobacterial_NP ASN_NP susceptibility_NN assays_NNS ._SENT Mycobacterial_JJ isolates_NNS were_VBD incubated_VBN for_IN 16_CD h_NN in_IN 7H9_JJ medium_NN (_( pH_NN 5.3_CD )_) and_CC then_RB plated_VBN onto_IN 7H11_JJ agar_NN ._SENT CFU_NP were_VBD determined_VBN at_IN 21_CD and_CC 50_CD days_NNS of_IN incubation_NN ._SENT (_( A_NP )_) Isolates_NNS were_VBD incubated_VBN at_IN 37C_JJ in_IN 7H9_JJ broth_NN at_IN pH_NN 5.3_CD without_IN NaNO2_NP ,_, and_CC CFU_NP were_VBD quantified_VBN at_IN day_NN 21_CD (_( shaded_JJ bars_NNS )_) and_CC day_NN 50_CD (_( hatched_VBN bars_NNS )_) ._SENT The_DT results_NNS are_VBP expressed_VBN as_IN the_DT CFU_NP +-_NN the_DT standard_JJ error_NN of_IN the_DT mean_JJ (_( SEM_NP )_) ._SENT (_( B_LS )_) Isolates_NNS were_VBD exposed_VBN to_TO 3_CD mM_NNS (_( day_NN 21_CD [_SYM black_JJ diamonds_NNS ]_SYM and_CC day_NN 50_CD [_SYM solid_JJ squares_NNS ]_SYM )_) and_CC 6_CD mM_NP NaNO2_NP (_( day_NN 21_CD [_SYM gray_JJ triangles_NNS ]_SYM and_CC day_NN 50_CD [_SYM gray_JJ circles_NNS ]_SYM )_) ._SENT The_DT results_NNS are_VBP expressed_VBN as_IN the_DT percent_NN survival_NN based_VBN on_IN the_DT CFU_NP recovered_VBD from_IN ASN-exposed_JJ strains_NNS relative_JJ to_TO the_DT CFU_NP of_IN unexposed_JJ strains_NNS +-_NN the_DT SEM_NP ._SENT Both_DT graphs_NNS are_VBP representative_JJ of_IN triplicate_JJ experiments_NNS and_CC show_VB mean_JJ values_NNS of_IN triplicate_JJ cultures_NNS for_IN each_DT strain_NN ._SENT FIG._NN 2_CD ._SENT |_SYM Mycobacterial_NP H2O2_NP susceptibility_NN assays_NNS ._SENT Mycobacterial_NP H2O2_NP susceptibility_NN assays_NNS ._SENT Mycobacterial_JJ isolates_NNS were_VBD incubated_VBN for_IN 16_CD h_NN in_IN 7H9_JJ medium_NN (_( pH_NN 7.0_CD )_) and_CC then_RB plated_VBN onto_IN 7H11_JJ agar_NN ._SENT CFU_NP were_VBD determined_VBN at_IN 21_CD and_CC 50_CD days_NNS of_IN incubation_NN ._SENT (_( A_NP )_) Isolates_NNS were_VBD incubated_VBN at_IN 37C_JJ in_IN 7H9_JJ broth_NN at_IN pH_NN 7.0_CD without_IN H2O2_NP ,_, and_CC CFU_NP were_VBD quantified_VBN at_IN day_NN 21_CD (_( shaded_JJ bars_NNS )_) and_CC day_NN 50_CD (_( hatched_VBN bars_NNS )_) ._SENT The_DT results_NNS are_VBP expressed_VBN as_IN CFU_NP +-_NN the_DT SEM_NP ._SENT (_( B_LS )_) Isolates_NNS were_VBD exposed_VBN to_TO 2_CD mM_NNS (_( day_NN 21_CD [_SYM black_JJ diamonds_NNS ]_SYM and_CC day_NN 50_CD [_SYM black_JJ squares_NNS ]_SYM )_) and_CC 5_CD mM_NP H2O2_NP (_( day_NN 21_CD [_SYM gray_JJ triangles_NNS ]_SYM and_CC day_NN 50_CD [_SYM gray_JJ circles_NNS ]_SYM )_) ._SENT The_DT results_NNS are_VBP expressed_VBN as_IN the_DT percent_NN survival_NN based_VBN on_IN CFU_NP recovered_VBD from_IN strains_NNS exposed_VBN to_TO H2O2_NP relative_JJ to_TO the_DT CFU_NP of_IN unexposed_JJ strains_NNS +-_NN the_DT SEM_NP ._SENT Both_DT graphs_NNS are_VBP representative_JJ of_IN triplicate_JJ experiments_NNS and_CC show_VB mean_JJ values_NNS of_IN triplicate_JJ cultures_NNS for_IN each_DT strain_NN ._SENT TABLE_NN 2_CD |_SYM Comparison_NN to_TO laboratory_NN strain_NN H37Ra_NP of_IN resistance_NN levels_NNS of_IN each_DT strain_NN to_TO ASN_NP and_CC H2O2_NP Our_NP results_NNS demonstrate_VBP that_IN ,_, at_IN a_DT low_JJ concentration_NN of_IN ASN_NP ,_, the_DT tested_VBN Mycobacterium_NN strains_NNS display_VBP a_DT greater_JJR level_NN of_IN variation_NN in_IN percent_NN survival_NN at_IN 21_CD days_NNS of_IN incubation_NN compared_VBN to_TO that_WDT observed_VBD at_IN 50_CD days_NNS of_IN incubation_NN ._SENT However_RB ,_, at_IN high_JJ concentrations_NNS of_IN ASN_NP ,_, these_DT differences_NNS in_IN the_DT percent_NN survival_NN at_IN both_DT day_NN 21_CD and_CC day_NN 50_CD disappeared_VBN for_IN each_DT strain_NN ._SENT Significant_JJ differences_NNS in_IN the_DT percent_NN survival_NN of_IN the_DT clinical_JJ isolates_NNS at_IN the_DT two_CD time_NN points_NNS were_VBD not_RB observed_VBN when_WRB they_PP were_VBD exposed_VBN to_TO either_DT concentration_NN of_IN H2O2_NP ._SENT These_DT data_NNS suggest_VBP that_IN the_DT RNI_NP products_NNS ,_, but_CC not_RB H2O2_JJ ,_, exert_VB a_DT bacteriostatic_JJ effect_NN at_IN low_JJ concentrations_NNS and_CC a_DT bactericidal_JJ effect_NN at_IN high_JJ concentrations_NNS ._SENT Considering_VBG that_DT most_RBS mycobacterial_JJ strains_NNS were_VBD able_JJ to_TO recover_VB from_IN exposure_NN to_TO lower_JJR concentrations_NNS of_IN ASN_NP when_WRB allowed_VBN to_TO incubate_VB beyond_IN 3_CD weeks_NNS ,_, it_PP appears_VBZ that_IN the_DT time_NN of_IN incubation_NN after_IN which_WDT CFU_NP data_NNS are_VBP analyzed_VBN is_VBZ important_JJ when_WRB similar_JJ assays_NNS are_VBP used_VBN to_TO determine_VB mycobacterial_JJ susceptibility_NN to_TO any_DT type_NN of_IN stress_NN ._SENT Although_IN all_DT of_IN the_DT strains_NNS in_IN the_DT present_JJ study_NN exhibited_VBD some_DT level_NN of_IN recovery_NN to_TO low_JJ concentrations_NNS of_IN H2O2_NP ,_, the_DT differences_NNS in_IN the_DT percent_NN survival_NN between_IN day_NN 21_CD and_CC day_NN 50_CD within_IN each_DT strain_NN were_VBD not_RB statistically_RB significant_JJ ,_, with_IN the_DT exception_NN of_IN one_CD strain_NN (_( H37Ra_NP )_) ._SENT One_CD explanation_NN for_IN this_DT observation_NN is_VBZ that_IN the_DT concentrations_NNS of_IN H2O2_NP we_PP used_VBD are_VBP bactericidal_JJ to_TO Mycobacterium_NN ._SENT Another_DT possibility_NN may_MD be_VB that_IN most_JJS strains_NNS of_IN mycobacteria_NNS ,_, except_IN H37Ra_NP ,_, are_VBP more_RBR resistant_JJ to_TO H2O2_NP at_IN 2_CD mM_NNS ,_, and_CC thus_RB they_PP are_VBP able_JJ to_TO grow_VB within_IN 3_CD weeks_NNS ._SENT Hence_RB ,_, the_DT concentrations_NNS of_IN H2O2_NP used_VBN in_IN the_DT present_JJ study_NN may_MD have_VB been_VBN either_RB too_RB low_JJ (_( 2_CD mM_NNS )_) or_CC too_RB high_JJ (_( 5_CD mM_NNS )_) to_TO see_VB significant_JJ differences_NNS among_IN all_DT of_IN the_DT strains_NNS when_WRB we_PP compared_VBD the_DT percent_NN survival_NN values_NNS at_IN days_NNS 21_CD and_CC 50_CD ._SENT These_DT hypotheses_NNS are_VBP in_IN accord_NN with_IN other_JJ studies_NNS that_WDT have_VBP demonstrated_VBN either_CC that_IN H2O2_NP is_VBZ bactericidal_JJ in_IN vitro_NN or_CC that_DT M._NP tuberculosis_NN is_VBZ relatively_RB resistant_JJ to_TO the_DT effects_NNS of_IN H2O2_NP in_IN a_DT cell-free_JJ system_NN ._SENT Since_IN H37Ra_NP has_VBZ a_DT much_RB slower_JJR growth_NN rate_NN than_IN the_DT other_JJ strains_NNS used_VBN ,_, the_DT significant_JJ level_NN of_IN recovery_NN seen_VBN at_IN all_DT concentrations_NNS of_IN ASN_NP and_CC H2O2_NP may_MD be_VB a_DT consequence_NN of_IN not_RB being_VBG able_JJ to_TO visualize_VB the_DT colonies_NNS until_IN much_RB later_RBR ._SENT We_PP tried_VBD to_TO minimize_VB this_DT effect_NN by_IN determining_VBG the_DT initial_JJ CFU_NP of_IN H37Ra_NP at_IN day_NN 26_CD instead_RB of_IN at_IN day_NN 21_CD ,_, thus_RB allowing_VBG the_DT organism_NN sufficient_JJ time_NN to_TO grow_VB ._SENT Collectively_RB ,_, our_PP$ data_NNS indicate_VBP that_IN under_IN the_DT in_IN vitro_NN conditions_NNS used_VBD here_RB exposure_NN to_TO low_JJ concentrations_NNS of_IN ASN_NP resulted_VBD in_IN the_DT stasis_NN of_IN most_JJS clinical_JJ isolates_NNS of_IN M._NP tuberculosis_NN ._SENT In_IN contrast_NN to_TO these_DT data_NNS ,_, a_DT study_NN by_IN Chan_NP et_FW al._FW found_VBD that_IN chemically_RB generated_VBN RNI_NP at_IN concentrations_NNS of_IN between_IN 1.0_CD and_CC 10_CD mM_NNS are_VBP bactericidal_JJ to_TO M._NP tuberculosis_NN in_IN vitro_NN ,_, although_IN it_PP should_MD be_VB noted_VBN that_IN only_RB one_CD strain_NN (_( Erdman_NP )_) was_VBD analyzed_VBN and_CC that_IN the_DT incubation_NN period_NN after_IN which_WDT CFU_NP were_VBD enumerated_VBN was_VBD not_RB clearly_RB defined_VBN ._SENT Our_PP$ results_NNS are_VBP consistent_JJ with_IN those_DT of_IN Rhoades_NP and_CC Orme_NP ,_, who_WP demonstrated_VBD in_IN vitro_NN that_IN the_DT antimycobacterial_JJ activity_NN of_IN interferon-primed_JJ macrophages_NNS was_VBD bacteriostatic_JJ rather_RB than_IN bactericidal_JJ ._SENT In_IN addition_NN ,_, Rhoades_NP and_CC Orme_NP found_VBD that_IN a_DT high_JJ concentration_NN (_( 10_CD mM_NNS )_) of_IN NaNO2_NP was_VBD mycobactericidal_JJ in_IN a_DT cell-free_JJ system_NN and_CC that_IN lower_JJR concentrations_NNS (_( 0.1_CD to_TO 5.0_CD mM_NNS )_) showed_VBD a_DT range_NN of_IN tolerance_NN by_IN clinical_JJ mycobacterial_JJ isolates_NNS ._SENT It_PP should_MD be_VB noted_VBN that_IN the_DT cell-free_JJ assay_NN used_VBN in_IN the_DT Rhoads_NP and_CC Orme_NP study_NN ,_, although_IN similar_JJ ,_, was_VBD not_RB identical_JJ to_TO ours_PP ._SENT Our_PP$ study_NN exposed_VBN mycobacterial_JJ strains_NNS for_IN 16_CD h_NN as_IN opposed_VBN to_TO a_DT period_NN of_IN 10_CD days_NNS ,_, and_CC the_DT CFU_NP in_IN the_DT Rhoades_NP and_CC Orme_NP study_NN were_VBD determined_VBN at_IN between_IN 3_CD and_CC 4_CD weeks_NNS ._SENT Despite_IN the_DT observed_JJ bacteriostatic_JJ effect_NN of_IN RNI_NP ,_, our_PP$ results_NNS also_RB demonstrate_VBP that_IN some_DT clinical_JJ M._NP tuberculosis_NN isolates_VBZ (_( CDC1551_NP and_CC CB3.3_NP )_) are_VBP able_JJ to_TO resist_VB even_RB high_JJ concentrations_NNS of_IN ASN_NP or_CC H2O2_NP ._SENT These_DT clinical_JJ isolates_NNS were_VBD previously_RB shown_VBN to_TO be_VB associated_VBN with_IN large_JJ outbreaks_NNS of_IN tuberculosis_NN and_CC were_VBD found_VBN to_TO exhibit_VB high_JJ levels_NNS of_IN resistance_NN to_TO RNI_NP and_CC H2O2_NP compared_VBN to_TO other_JJ clinical_JJ isolates_NNS or_CC laboratory_NN strains_NNS of_IN M._NP tuberculosis_NN ._SENT These_DT observations_NNS are_VBP consistent_JJ with_IN numerous_JJ studies_NNS that_WDT have_VBP demonstrated_VBN strain-related_JJ differences_NNS regarding_VBG susceptibility_NN to_TO RNI_NP and_CC ROI_NP ,_, and_CC suggest_VBP that_IN certain_JJ strains_NNS of_IN M._NP tuberculosis_NN have_VBP evolved_VBN an_DT enhanced_JJ level_NN of_IN resistance_NN to_TO the_DT antibacterial_NN mechanisms_NNS elicited_VBN by_IN the_DT host_NN macrophage_NN ._SENT The_DT physiologic_JJ concentrations_NNS of_IN ROI_NP and_CC RNI_NP within_IN human_JJ macrophages_NNS in_IN vivo_JJ are_VBP not_RB well_RB established_VBN ,_, although_IN in_IN vitro_NN studies_NNS have_VBP determined_VBN that_WDT ca_MD ._SENT 3.2_CD nmol_NN of_IN NO2-/105_NP cells_NNS and_CC 287_CD nmol_NN of_IN H2O2/mg_NP of_IN protein/h_NN are_VBP generated_VBN from_IN resident_JJ murine_JJ macrophages_NNS stimulated_VBN with_IN IFN-gamma_NP ._SENT In_IN addition_NN ,_, other_JJ studies_NNS have_VBP demonstrated_VBN that_IN between_IN 34_CD and_CC 241_CD nmol_NN of_IN nitrite/106_JJ cells_NNS in_IN culture_NN supernatants_NNS of_IN human_JJ peripheral_JJ blood_NN monocytes_NNS infected_VBN with_IN M._NP tuberculosis_NN and_CC between_IN 10_CD and_CC 80_CD pmol_NN of_IN H2O2/mug_NP of_IN DNA_NP from_IN cells_NNS stimulated_VBN with_IN polystyrene_NN particles_NNS are_VBP generated_VBN ._SENT Hence_RB ,_, the_DT amount_NN of_IN ROI_NP and_CC RNI_NP added_VBD in_IN the_DT cell-free_JJ system_NN used_VBN in_IN the_DT present_JJ study_NN is_VBZ higher_JJR than_IN that_DT expected_VBN to_TO be_VB generated_VBN in_IN vivo_RB ._SENT Therefore_RB ,_, relatively_RB resistant_JJ M._NP tuberculosis_NN strains_NNS ,_, such_JJ as_IN CB3.3_NP and_CC CDC1551_NP ,_, are_VBP less_RBR likely_JJ to_TO be_VB kept_VBN in_IN check_NN within_IN the_DT host_NN ._SENT Consequently_RB ,_, one_PP could_MD postulate_VB that_IN such_JJ strains_NNS are_VBP more_RBR capable_JJ of_IN causing_VBG active_JJ disease_NN more_RBR readily_RB after_IN an_DT initial_JJ infection_NN than_IN strains_NNS that_WDT are_VBP relatively_RB susceptible_JJ to_TO RNI_NP and_CC ROI_NP ._SENT In_IN contrast_NN ,_, the_DT proliferation_NN of_IN RNI-_NP and_CC ROI-susceptible_NP strains_NNS may_MD be_VB controlled_VBN as_RB long_RB as_IN the_DT host_NN is_VBZ able_JJ to_TO maintain_VB RNI_NP and/or_CC ROI_NP expression_NN ._SENT In_IN the_DT absence_NN of_IN these_DT stresses_NNS ,_, such_JJ M._NP tuberculosis_NN strains_NNS may_MD resume_VB proliferation_NN and_CC cause_VB the_DT reactivation_NN of_IN disease_NN ._SENT While_IN there_EX may_MD be_VB multiple_JJ other_JJ host_NN factors_NNS that_WDT contribute_VBP to_TO bacteriostasis_NN of_IN M._NP tuberculosis_NN in_IN vivo_RB ,_, the_DT observation_NN of_IN the_DT bacteriostatic_JJ effect_NN of_IN RNI_NP made_VBD in_IN vitro_NN ,_, as_RB well_RB as_IN the_DT wide_JJ range_NN of_IN RNI_NP and/or_CC ROI_NP susceptibilities_NNS of_IN the_DT clinical_JJ isolates_NNS ,_, may_MD provide_VB new_JJ clues_NNS about_IN the_DT different_JJ clinical_JJ outcomes_NNS after_IN M._NP tuberculosis_NN infection_NN ._SENT 